Yes, you can absolutely give oral linezolid to a trached and vented patient with pneumonia.
Oral linezolid is equivalent to IV linezolid for treating pneumonia in mechanically ventilated patients because it has 100% bioavailability, making route of administration irrelevant to efficacy. 1
Key Pharmacokinetic Evidence
The FDA label clearly demonstrates that oral linezolid achieves identical systemic exposure to IV administration:
- Absolute bioavailability is approximately 100% 1
- Maximum plasma concentrations (Cmax) are nearly identical: 12.7 µg/mL (oral) vs 12.9 µg/mL (IV) 1
- Area under the curve (AUC) values are equivalent: 91.4 µg·h/mL (oral) vs 80.2 µg·h/mL (IV) 1
- "Linezolid may be given orally or intravenously without dose adjustment" 1
Guideline Support
The 2016 IDSA/ATS guidelines for hospital-acquired and ventilator-associated pneumonia recommend linezolid 600 mg IV q12h as a first-line option for empiric MRSA coverage 2. The guidelines specify IV dosing in their tables, but this reflects convention rather than necessity—the pharmacokinetic data proves oral administration delivers identical drug exposure.
For confirmed MRSA pneumonia, both IV vancomycin and linezolid 600 mg PO/IV twice daily are equally recommended 3, explicitly acknowledging the interchangeability of routes.
Practical Administration
- Dose: 600 mg every 12 hours, oral or IV 2, 3
- Can be administered via feeding tube if the patient cannot swallow
- Food does not significantly affect absorption (AUC remains similar, though Cmax decreases 17%) 1
- Duration: 7-21 days depending on severity and response 3
Clinical Trial Evidence
Multiple pneumonia trials used IV-to-oral sequential therapy as the standard protocol 1. In the nosocomial pneumonia trial, patients received "ZYVOX I.V. Injection 600 mg q12h followed by ZYVOX Tablets 600 mg q12h" with 57% cure rates in the modified intent-to-treat analysis 1. This IV-to-oral transition strategy is explicitly validated in the evidence base.
Common Pitfall to Avoid
Do not assume that mechanical ventilation or tracheostomy necessitates IV antibiotics. This is a pervasive misconception. The presence of an endotracheal tube or tracheostomy does not impair GI absorption. Linezolid's complete oral bioavailability makes it ideal for de-escalation from IV to oral therapy even in critically ill, ventilated patients—reducing line-related complications and costs without sacrificing efficacy.
Safety Consideration in Ventilated Patients
One recent retrospective study found increased in-hospital mortality when linezolid was combined with fentanyl in mechanically ventilated patients (HR 1.56,95% CI 1.0-2.43) 4, possibly related to serotonin syndrome risk. However, this was a small study (n=43) requiring validation. Monitor for serotonin syndrome symptoms if using concurrent opioids, but this does not contraindicate oral administration.